Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | YH32367 |
Synonyms | |
Therapy Description |
YH32367 (ABL105) is a bispectific antibody targeting ERBB2 (HER2) and TNFRSF9 (4-1BB), which potentially enhances antitumor immune response and inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1139). |